Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Vidal

Showing results (121-130 of 130) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 130 results.
Frontiers in Pharmacology|August 9, 2020
Corrigendum: Influence of Polymorphisms Involved in Platelet Activation and Inflammatory Response on Aspirin-Related Upper Gastrointestinal Bleeding: A Case-Control StudyNarmeen Mallah, Maruxa Zapata-Cachafeiro, Carmelo Aguirre, et al.
Biochemical Pharmacology|June 18, 2026
Anakinra prevents high glucose-mediated potentiation of IL-1β-induced NLRP3 inflammasome activation, small extracellular vesicle release and vascular inflammationInés Valencia, Xavier Vidal-Gómez, Álvaro San Hipólito-Luengo, et al.
Scientific Reports|October 8, 2021
A multicenter case-control study of the effect of e-nos VNTR polymorphism on upper gastrointestinal hemorrhage in NSAID usersNarmeen Mallah, Maruxa Zapata-Cachafeiro, Carmelo Aguirre, et al.
Annals of Medicine|February 4, 2022
Synergism interaction between genetic polymorphisms in drug metabolizing enzymes and NSAIDs on upper gastrointestinal haemorrhage: a multicenter case-control studyNarmeen Mallah, Maruxa Zapata-Cachafeiro, Carmelo Aguirre, et al.
Circulation Research|June 17, 2020
Large Extracellular Vesicle-Associated Rap1 Accumulates in Atherosclerotic Plaques, Correlates With Vascular Risks and Is Involved in AtherosclerosisLiliana Perdomo, Xavier Vidal-Gómez, Raffaella Soleti, et al.
Multiple Sclerosis and Related Disorders|April 22, 2023
Validation of the Spanish version of DYsphagia in MUltiple Sclerosis questionnaire (DYMUS)Marta Renom, Ingrid Galán, Xavier Vidal, et al.
Basic & Clinical Pharmacology & Toxicology|October 10, 2020
Prescribers' compliance with summary of product characteristics of dabigatran, rivaroxaban and apixaban-A European comparative drug utilization studyMarietta Rottenkolber, Sven Schmiedl, Luisa Ibánez, et al.
Biomolecules|November 11, 2022
Oxidative Stress in Structural Valve Deterioration: A Longitudinal Clinical StudyManuel Galiñanes, Kelly Casós, Arnau Blasco-Lucas, et al.
British Journal of Clinical Pharmacology|July 19, 2019
Incidence of direct oral anticoagulant use in patients with nonvalvular atrial fibrillation and characteristics of users in 6 European countries (2008-2015): A cross-national drug utilization studyLuisa Ibáñez, Mònica Sabaté, Xavier Vidal, et al.
Frontiers in Pharmacology|September 4, 2023
Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy, Netherlands, and Spain: an interrupted time series analysisCarlos E Durán, Judit Riera-Arnau, Shahab Abtahi, et al.
Pageof 13

Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
Frontiers in Pharmacology|August 9, 2020
Corrigendum: Influence of Polymorphisms Involved in Platelet Activation and Inflammatory Response on Aspirin-Related Upper Gastrointestinal Bleeding: A Case-Control StudyNarmeen Mallah, Maruxa Zapata-Cachafeiro, Carmelo Aguirre, et al.
Biochemical Pharmacology|June 18, 2026
Anakinra prevents high glucose-mediated potentiation of IL-1β-induced NLRP3 inflammasome activation, small extracellular vesicle release and vascular inflammationInés Valencia, Xavier Vidal-Gómez, Álvaro San Hipólito-Luengo, et al.
Scientific Reports|October 8, 2021
A multicenter case-control study of the effect of e-nos VNTR polymorphism on upper gastrointestinal hemorrhage in NSAID usersNarmeen Mallah, Maruxa Zapata-Cachafeiro, Carmelo Aguirre, et al.
Annals of Medicine|February 4, 2022
Synergism interaction between genetic polymorphisms in drug metabolizing enzymes and NSAIDs on upper gastrointestinal haemorrhage: a multicenter case-control studyNarmeen Mallah, Maruxa Zapata-Cachafeiro, Carmelo Aguirre, et al.
Circulation Research|June 17, 2020
Large Extracellular Vesicle-Associated Rap1 Accumulates in Atherosclerotic Plaques, Correlates With Vascular Risks and Is Involved in AtherosclerosisLiliana Perdomo, Xavier Vidal-Gómez, Raffaella Soleti, et al.
Multiple Sclerosis and Related Disorders|April 22, 2023
Validation of the Spanish version of DYsphagia in MUltiple Sclerosis questionnaire (DYMUS)Marta Renom, Ingrid Galán, Xavier Vidal, et al.
Basic & Clinical Pharmacology & Toxicology|October 10, 2020
Prescribers' compliance with summary of product characteristics of dabigatran, rivaroxaban and apixaban-A European comparative drug utilization studyMarietta Rottenkolber, Sven Schmiedl, Luisa Ibánez, et al.
Biomolecules|November 11, 2022
Oxidative Stress in Structural Valve Deterioration: A Longitudinal Clinical StudyManuel Galiñanes, Kelly Casós, Arnau Blasco-Lucas, et al.
British Journal of Clinical Pharmacology|July 19, 2019
Incidence of direct oral anticoagulant use in patients with nonvalvular atrial fibrillation and characteristics of users in 6 European countries (2008-2015): A cross-national drug utilization studyLuisa Ibáñez, Mònica Sabaté, Xavier Vidal, et al.
Frontiers in Pharmacology|September 4, 2023
Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy, Netherlands, and Spain: an interrupted time series analysisCarlos E Durán, Judit Riera-Arnau, Shahab Abtahi, et al.
Pageof 13